{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:51:40Z","timestamp":1768294300192,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T00:00:00Z","timestamp":1455926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s10072-016-2512-2","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T08:49:16Z","timestamp":1455958156000},"page":"907-920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dose effects of lacosamide as add-on therapy for partial-onset seizure in adult"],"prefix":"10.1007","volume":"37","author":[{"given":"Deng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,20]]},"reference":[{"key":"2512_CR1","doi-asserted-by":"crossref","unstructured":"ILAE\/IBE\/WHO Global Campaign against Epilepsy (2001) Out of the shadows campaign. http:\/\/www.who.int\/mental_health\/media\/en\/37.pdf?ua=1","DOI":"10.1006\/ebeh.2000.0104"},{"key":"2512_CR2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","volume":"22","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1981","unstructured":"Commission on Classification and Terminology of the International League Against Epilepsy (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 22:489\u2013501","journal-title":"Epilepsia"},{"key":"2512_CR3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 51:1069\u20131077","journal-title":"Epilepsia"},{"key":"2512_CR4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yebeh.2014.09.025","volume":"41","author":"H Azuma","year":"2014","unstructured":"Azuma H, Akechi T (2014) Effects of psychosocial functioning, depression, seizure frequency, and employment on quality of life in patients with epilepsy. Epilepsy Behav 41:18\u201320","journal-title":"Epilepsy Behav"},{"issue":"98\u2013101","key":"2512_CR5","first-page":"106","volume":"9","author":"MR Sperling","year":"2004","unstructured":"Sperling MR (2004) The consequences of uncontrolled epilepsy. CNS Spectr 9(98\u2013101):106\u2013109","journal-title":"CNS Spectr"},{"key":"2512_CR6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.yebeh.2007.05.002","volume":"11","author":"CL Harden","year":"2007","unstructured":"Harden CL, Maroof DA, Nikolov B et al (2007) The effect of seizure severity on quality of life in epilepsy. Epilepsy Behav 11:208\u2013211","journal-title":"Epilepsy Behav"},{"key":"2512_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.yebeh.2009.07.037","volume":"16","author":"RE Bautista","year":"2009","unstructured":"Bautista RE, Glen ET (2009) Seizure severity is associated with quality of life independent of seizure frequency. Epilepsy Behav 16:325\u2013329","journal-title":"Epilepsy Behav"},{"key":"2512_CR8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s40262-015-0276-0","volume":"54","author":"W Cawello","year":"2015","unstructured":"Cawello W (2015) Clinical pharmacokinetic and pharmacodynamic profile of lacosamide. Clin Pharmacokinet 54:901\u2013914","journal-title":"Clin Pharmacokinet"},{"key":"2512_CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2014.11.021","volume":"110","author":"MA Rogawski","year":"2015","unstructured":"Rogawski MA, Tofighy A, White HS et al (2015) Current understanding of the mechanism of action of the antiepileptic drug lacosamide. Epilepsy Res 110:189\u2013205","journal-title":"Epilepsy Res"},{"key":"2512_CR10","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1517\/14656566.2010.488639","volume":"11","author":"SS Chung","year":"2010","unstructured":"Chung SS (2010) Lacosamide: new adjunctive treatment option for partial-onset seizures. Expert Opin Pharmacother 11:1595\u20131602","journal-title":"Expert Opin Pharmacother"},{"key":"2512_CR11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/ane.12372","volume":"131","author":"IJ Dm","year":"2015","unstructured":"Dm IJ, Van Veenendaal TM, Majoie HJ et al (2015) Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy. Acta Neurol Scand 131:347\u2013354","journal-title":"Acta Neurol Scand"},{"key":"2512_CR12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pbb.2015.04.011","volume":"134","author":"SR Bang","year":"2015","unstructured":"Bang SR, Ambavade SD, Jagdale PG et al (2015) Lacosamide reduces HDAC levels in the brain and improves memory: potential for treatment of Alzheimer\u2019s disease. Pharmacol Biochem Behav 134:65\u201369","journal-title":"Pharmacol Biochem Behav"},{"key":"2512_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrd2813","volume":"8","author":"B Hughes","year":"2009","unstructured":"Hughes B (2009) 2008 FDA drug approvals. Nature reviews. Drug Discov 8:93\u201396","journal-title":"Drug Discov"},{"key":"2512_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2014.11.007","volume":"25","author":"V Paquette","year":"2015","unstructured":"Paquette V, Culley C, Greanya ED et al (2015) Lacosamide as adjunctive therapy in refractory epilepsy in adults: a systematic review. Seizure 25:1\u201317","journal-title":"Seizure"},{"key":"2512_CR15","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100","journal-title":"PLoS Med"},{"key":"2512_CR16","unstructured":"The Cochrane Collaboration (2014) RevMan 5.3 user guide. The Cochrane Collaboration. Available with RevMan 5.3 software at http:\/\/tech.cochrane.org\/revman\/download"},{"key":"2512_CR17","unstructured":"The Cochrane Collaboration (2011) Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration. http:\/\/community.cochrane.org\/handbook"},{"key":"2512_CR18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. Br Med J 327:557\u2013560","journal-title":"Br Med J"},{"key":"2512_CR19","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1528-1167.2007.01188.x","volume":"48","author":"E Ben-Menachem","year":"2007","unstructured":"Ben-Menachem E, Biton V, Jatuzis D et al (2007) Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48:1308\u20131317","journal-title":"Epilepsia"},{"key":"2512_CR20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1528-1167.2008.01951.x","volume":"50","author":"P Halasz","year":"2009","unstructured":"Halasz P, Kalviainen R, Mazurkiewicz-Beldzinska M et al (2009) Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 50:443\u2013453","journal-title":"Epilepsia"},{"key":"2512_CR21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1528-1167.2009.02496.x","volume":"51","author":"S Chung","year":"2010","unstructured":"Chung S, Sperling MR, Biton V et al (2010) Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia 51:958\u2013967","journal-title":"Epilepsia"},{"key":"2512_CR22","unstructured":"UCB Pharma SA (2014) A multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of lacosamide as adjunctive therapy in Japanese and Chinese adults with uncontrolled partial-onset seizures with or without secondary generalization. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01710657?term=NCT01710657&rank=1"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-016-2512-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-016-2512-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-016-2512-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T20:29:13Z","timestamp":1567628953000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-016-2512-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,20]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["2512"],"URL":"https:\/\/doi.org\/10.1007\/s10072-016-2512-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,20]]}}}